- Home
- FOX vs BGNE Comparison
FOX vs BGNE Comparison
Compare FOX & BGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOX
- BGNE
- Stock Information
- Founded
- FOX 2018
- BGNE 2010
- Country
- FOX United States
- BGNE Cayman Islands
- Employees
- FOX N/A
- BGNE N/A
- Industry
- FOX Broadcasting
- BGNE Biotechnology: Pharmaceutical Preparations
- Sector
- FOX Industrials
- BGNE Health Care
- Exchange
- FOX Nasdaq
- BGNE Nasdaq
- Market Cap
- FOX 17.6B
- BGNE 21.0B
- IPO Year
- FOX N/A
- BGNE 2016
- Fundamental
- Price
- FOX $42.87
- BGNE $189.23
- Analyst Decision
- FOX
- BGNE Buy
- Analyst Count
- FOX 0
- BGNE 7
- Target Price
- FOX N/A
- BGNE $247.07
- AVG Volume (30 Days)
- FOX 898.4K
- BGNE 281.8K
- Earning Date
- FOX 11-04-2024
- BGNE 11-12-2024
- Dividend Yield
- FOX 1.24%
- BGNE N/A
- EPS Growth
- FOX 103.10
- BGNE N/A
- EPS
- FOX 4.07
- BGNE N/A
- Revenue
- FOX $14,337,000,000.00
- BGNE $3,351,304,621.00
- Revenue This Year
- FOX $12.69
- BGNE $969.39
- Revenue Next Year
- FOX N/A
- BGNE $24.79
- P/E Ratio
- FOX $10.51
- BGNE N/A
- Revenue Growth
- FOX N/A
- BGNE 50.22
- 52 Week Low
- FOX $25.82
- BGNE $126.97
- 52 Week High
- FOX $44.42
- BGNE $248.16
- Technical
- Relative Strength Index (RSI)
- FOX 66.13
- BGNE 31.72
- Support Level
- FOX $41.14
- BGNE $189.60
- Resistance Level
- FOX $43.68
- BGNE $209.29
- Average True Range (ATR)
- FOX 0.99
- BGNE 6.42
- MACD
- FOX 0.34
- BGNE -2.10
- Stochastic Oscillator
- FOX 74.02
- BGNE 9.19
About FOX Fox Corporation Class B
Fox operates in two segments: cable networks and television. Cable networks primarily includes Fox News, Fox Business, and several pay-TV sports stations. Television primarily includes the Fox broadcast network, 29 owned and operated local television stations, of which 18 are affiliated with the Fox network, and streaming platform Tubi, which is not subscription-based and is completely ad-supported. Fox effectively sold most of its entertainment assets to Disney in 2019, so it no longer creates entertainment content and relies heavily on live news and sports, with nearly all tied to the pay-TV bundle. The Murdoch family controls Fox.
About BGNE BeiGene Ltd.
BeiGene Ltd is a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. BeiGene's key cancer treatments are BRUKINSA (zanubrutinib), Bruton's tyrosine kinase (BTK) inhibitor, and TEVIMBRA (tislelizumab), an anti-PD-1 antibody. In addition, it has a diverse pipeline of novel therapeutics focusing on a range of malignancies, including AML, MDS, multiple myeloma, lung, gastrointestinal, breast, and gynecologic cancers. The Company operates in one segment: pharmaceutical products and is primarily located in the U.S. and the PRC. Key revenue is generated from the U.S.